Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 9/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30107570 | 1.00 | GRM5 (0.55) | GRM5KCNH2CYP1A2ALDH1A1MAPT | |
| Methyl Alcohol SCHEMBL28902013 | 0.83 | GRM5 (0.67) | GRM5KCNH2CYP1A2ALDH1A1MAPT | |
| SCHEMBL352291 | 0.83 | GRM5 (0.65) | GRM5KCNH2CYP1A2 | |
| SCHEMBL22548465 | 0.79 | GRM5 (0.49) | GRM5KCNH2CYP1A2 | |
| SCHEMBL29610604 | 0.79 | — | — | |
| SCHEMBL5560365 | 0.79 | — | — | |
| SCHEMBL4927688 | 0.78 | GRM5 (0.55) | GRM5KCNH2CYP1A2ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL22031723 | 0.77 | GRM5 (0.55) | GRM5KCNH2CYP1A2ALDH1A1MAPT | |
| SCHEMBL6765951 | 0.77 | GRM5 (0.50) | GRM5KCNH2CYP1A2ALDH1A1MAPT | |
| SCHEMBL1010178 | 0.77 | GRM5 (0.50) | GRM5KCNH2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111250164-B | Preparation method and application of modified MOR molecular sieve catalyst and method for preparing ethylene from coal-based ethanol | 中国科学院大连化学物理研究所 | 2023-04-07 | — | — | CN | claimed |
| CN-111416154-B | Silicon-based pyridine additive for high-voltage lithium ion battery electrolyte, electrolyte and battery | 松山湖材料实验室 | 2021-08-06 | — | — | CN | claimed |
| CN-113130855-A | Surface passivation composition and passivation solution of metal lithium and preparation method of passivation solution | 昆山宝创新能源科技有限公司 | 2021-07-16 | — | — | CN | claimed |
| CN-111416154-A | Silicon-based pyridine additive for high-voltage lithium ion battery electrolyte, electrolyte and battery | 松山湖材料实验室 | 2020-07-14 | — | — | CN | claimed |
| CN-111250164-A | Preparation method and application of modified MOR molecular sieve catalyst, and method for preparing ethylene from coal-based ethanol | 中国科学院大连化学物理研究所 | 2020-06-09 | — | — | CN | claimed |
| CN-111205336-A | Pyridine-bridged double-ruthenium acetylene end group compound and preparation method and application thereof | 衡阳师范学院 | 2020-05-29 | — | — | CN | claimed |
| CN-111285874-B | RET inhibitor, pharmaceutical composition thereof and application thereof | 广东东阳光药业股份有限公司 | 2024-08-09 | — | — | CN | disclosed |
| US-11827666-B2 | Galactoside inhibitor of galectins | GALECTO BIOTECH AB (DK) | 2023-11-28 | — | — | US | disclosed |
| US-RE49735-E1 | Oxazolidinones as modulators of MGLUR5 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| US-RE49735-E1 | Oxazolidinones as modulators of MGLUR5 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| US-RE49735-E1 | Oxazolidinones as modulators of MGLUR5 | BRISTOL-MYERS SQUIBB COMPANY (US) | 2023-11-28 | — | — | US | disclosed |
| EP-4225742-A1 | 5- AND 6-AZAINDOLE COMPOUNDS FOR INHIBITION OF BCR-ABL TYROSINE KINASES | Enliven Therapeutics, Inc. (US) | 2023-08-16 | — | — | EP | disclosed |
| CN-111250164-B | Preparation method and application of modified MOR molecular sieve catalyst and method for preparing ethylene from coal-based ethanol | 中国科学院大连化学物理研究所 | 2023-04-07 | — | — | CN | disclosed |
| WO-1998020002-A1 | DIPYRIDO[2,3-B:3',2'-F]AZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) | 1998-05-14 | — | — | WO | disclosed |
| US-5639753-A | CONTROLLING INSECTS IN AGRICULTURE CROPS | FMC CORPORATION (US) | 1997-06-17 | — | — | US | disclosed |
| WO-1997019924-A1 | CYCLOHEXYLMETHYL- AND CYCLOHEXYLIDENEMETHYL PYRIDINES, PROCESSES FOR THEIR PRODUCTION, AGENTS CONTAINING THEM AND THEIR USE AS PESTICIDES AND FUNGICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 1997-06-05 | — | — | WO | disclosed |
| WO-1997019923-A1 | CYCLOALKYLMETHYL- AND CYCLOALKYLIDENEMETHYL PYRIDINES, PROCESSES FOR THEIR PRODUCTION, AGENTS CONTAINING THEM AND THEIR USE AS PESTICIDES AND FUNGICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 1997-06-05 | — | — | WO | disclosed |
| US-5532367-A | LARVICIDES | FMC CORPORATION (US) | 1996-07-02 | — | — | US | disclosed |
| US-5521190-A | USEFUL AGAINST TOBACCO BUDWORM | FMC CORPORATION (US) | 1996-05-28 | — | — | US | disclosed |
| WO-1994027439-A1 | INSECTICIDAL PTERIDINES AND 8-DEAZAPTERIDINES | FMC CORPORATION (US) | 1994-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11827666-B2 | Galactoside inhibitor of galectins | LGALS1, LGALS2, LGALS3 | GRM5 1581/4885KCNH2 4653/4885CYP1A2 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.